| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |